Snacking, Satiety &Weight: A Randomized, Controlled Trial
NCT ID: NCT02050165
Last Updated: 2020-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2012-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Snacks and Satiety
NCT03947281
A Comparison of Satiety Effects Two Commercially Available Snack Bars
NCT07227701
The Effects of Snack Size and Variety on Appetite Control, Satiety, and Eating Behavior in Healthy Adults.
NCT03940105
Liking of Snack Foods - Sub-Study 1
NCT00200213
The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control
NCT02480582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotheses:
1. Snacking on nutrient-dense, highly satiating snack foods (i.e. KIND snacks with almonds) as compared to snacking on nutrient-dilute, energy-dense foods (i.e., conventional snack foods) will contribute to satiety, weight loss, and health improvements.
2. The benefits of healthful snacking are enhanced when portion size is clearly defined and controlled by packaging.
3. These effects will be seen even when study participants are given clear guidance about the calorie content of snack items, and how to make room for those calories in their diets.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KIND Bar
Daily inclusion of KIND Bars with almonds as a primary ingredient as part of the participant's usual diet, with diet counseling to adjust for the calories from the KIND Bars. KIND Bars that we will use in the study will include: Dark Chocolate Chili Almond; Cranberry Almond; Almond Walnut Macadamia; Pomegranate Blueberry Pistachio; Nut Delight; Fruit and Nut Delight; Almond and Apricot; Blueberry Pecan and Fiber.
KIND Bars
Consumption of KIND Bars for 12 weeks
Typical American Snack
Daily inclusion of conventional snacks (as part of the participant's usual diet, with diet counseling to adjust for the calories from the snacks. The snacks will consist of cookies considered to be conventional snack foods that are nutrient-dilute (i.e. relatively low in nutrients) and energy-dense (i.e., relatively high in kcal). Examples of conventional snack foods will include: Nabisco Snackwell Creme Sandwich 1.7 oz pack, Nabisco Newtons Fig 2 oz pack, Nabisco Cips Ahoy! Chocolate Chip 1.4 oz pack, and Nabisco Oreo Double Stuff Chocolate 1.3 oz pack.
Typical American Snack
Consumption of typical American snacks for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KIND Bars
Consumption of KIND Bars for 12 weeks
Typical American Snack
Consumption of typical American snacks for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smoker;
* Sedentary;
* Overweight (BMI ≥25kg/m²) with waist circumference \>40 inches (102 cm) for men and \>35 inches (88 cm) for women;
* Interested in losing weight, but not actively involved with a diet or weight loss program.
* Snack regularly with pre-packaged snacks typically available in grocery stores or vending machines.
* Willing to consume snacks on a daily basis.
* Anticipated inability to complete study protocol for any reason;
* Current eating disorder;
* Diabetes;
* Sleep apnea;
* Actively involved with a diet or weight loss program;
* Other restricted diets due to allergy/intolerance (i.e. nut, gluten) or by choice (i.e., vegetarian, vegan);
* Regular exercise as defined by participating in moderate-intensity for at least 150 minutes/week.
25 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kind LLC
UNKNOWN
Griffin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David L. Katz, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Yale-Griffin Prevention Research Center
Valentine Y. Njike, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Yale-Griffin Preventin Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale-Griffin Prevention Research Center
Derby, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.